Cambridge IGCSE Biology Notes 15: Drugs

Study guide

Cambridge IGCSE Biology 0610 and 0970 notes on drugs, antibiotic treatment, bacteria, viruses, resistant bacteria, essential use and MRSA.

Topic 15 of Cambridge IGCSE Biology 0610 and 0970 has one focused boundary: define drugs, explain the appropriate use and limits of antibiotics, recognise resistant bacteria and explain why essential-only antibiotic use can slow resistance such as MRSA. Alcohol, heroin, addiction and tolerance are not imported into the current official section 15.1.

A Cambridge IGCSE Biology antibiotics map connecting bacterial treatment and viral non-response to selection of resistant bacteria and essential-use control

Drug definition

A drug is any substance taken into the body that modifies or affects chemical reactions in the body. The definition includes medicines as well as other substances, but this Topic 15 outcome develops antibiotics specifically.

"Taken into the body" can involve different routes, while "modifies chemical reactions" identifies a biological effect. A food is not automatically called a drug simply because it contains chemicals; apply the official definition and context.

The word drug does not itself mean harmful, illegal or addictive. Antibiotics are medicinal drugs when used to treat appropriate infections.

Antibiotics treat bacterial infections

Antibiotics are used to treat bacterial infections. They kill bacteria or prevent bacterial growth sufficiently for the infection to be controlled.

Different antibiotics act on bacterial targets. Detailed molecular target mechanisms are not required here, but the central distinction is that bacteria are cells with structures and processes that an antibiotic may disrupt.

A prescription must match the likely or confirmed bacterial cause. Symptoms alone may not distinguish bacterial from viral infection, so unnecessary treatment can expose bacteria to selection without helping the patient.

Antibiotics do not affect viruses

Viruses are not bacterial cells. They reproduce using host-cell machinery and lack the bacterial structures targeted by antibiotics. Antibiotics therefore do not kill viruses and do not treat a viral infection itself.

A person with a viral disease can sometimes also develop a bacterial infection, but that separate bacterial diagnosis is the reason an antibiotic might be used. The presence of severe symptoms does not convert a virus into a bacterium.

Avoid saying that antibiotics treat every pathogen. Pathogen is a broad disease-causing category; antibiotics in this boundary target bacteria.

Resistant bacteria

Some bacteria are resistant to particular antibiotics. Resistance means that the antibiotic no longer kills or stops those bacteria effectively at the treatment exposure.

Variation exists in a bacterial population. When an antibiotic is used, susceptible bacteria are killed or inhibited. Resistant bacteria are more likely to survive, reproduce and pass resistance information to descendants. The proportion of resistant bacteria can therefore increase.

The antibiotic does not make each bacterium decide to adapt. It creates a selection pressure: existing or newly arising resistant variants have a survival and reproductive advantage in that environment.

As resistant bacteria become more common, the antibiotic becomes less effective. Infection can last longer, spread to others or require different treatment.

Why unnecessary use accelerates resistance

Every antibiotic exposure that reaches bacteria can create selection pressure. If an antibiotic is taken when it is not medically needed, susceptible bacteria may still be removed while resistant ones survive, even though the treatment provides no useful benefit against a viral illness.

Using antibiotics only when essential reduces unnecessary selection events. This can slow the development and spread of resistant bacterial populations and preserve antibiotic effectiveness.

Essential use does not mean never using antibiotics. Failing to treat a serious susceptible bacterial infection can be dangerous. The aim is appropriate use based on bacterial need, the correct medicine and professional guidance.

Patients should follow the prescribed dose and timing. They should not share leftover antibiotics or use them for a different illness. Treatment decisions belong with qualified health professionals because infection type, drug choice, allergy and resistance patterns matter.

MRSA as an example

MRSA is a resistant bacterial example named in the syllabus. The initials refer to strains of Staphylococcus aureus resistant to methicillin and related antibiotics.

MRSA can spread between people, particularly where susceptible patients, wounds, close contact and antibiotic exposure create opportunities. Control depends on hygiene, infection-control procedures and careful antibiotic use.

Do not call MRSA a virus or a drug. It is resistant bacteria, and resistance describes the bacteria's response to an antibiotic.

Resistance belongs to bacteria

The human body does not "become resistant" to an antibiotic in this mechanism. Bacterial populations become resistant.

Tolerance and side effects in a person are different ideas and are outside this official Topic 15 boundary. A treatment may fail because the pathogen is resistant, because the disease is viral, because the wrong drug was selected or because exposure was insufficient. State the evidence rather than assuming one cause.

Resistance is also specific. A bacterium resistant to one antibiotic is not automatically resistant to every antibiotic. A report should name the tested drug or resistance pattern.

Interpret inhibition evidence

In a controlled test using an approved safe bacterial model, a clear zone around an antibiotic disc indicates reduced bacterial growth. A larger inhibition zone can support greater effectiveness under identical conditions.

Valid comparison requires the same bacterial strain, lawn density, agar depth, disc size, antibiotic amount, incubation time and temperature. Zone diameter alone cannot be compared across uncontrolled experiments.

No clear zone may indicate resistance, but method failure, an inactive disc or unsuitable conditions are alternatives. Positive and negative controls help distinguish these explanations.

Detailed culture handling belongs to supervised practical work. Unknown clinical microorganisms and potentially pathogenic bacteria must not be cultured in routine classroom work.

Worked application: explain a changing population

A bacterial culture contains 99 susceptible cells and one resistant cell before antibiotic exposure. Treatment kills most susceptible bacteria, but the resistant cell survives and divides. After repeated reproduction, resistant descendants form a much larger fraction of the population, so the same antibiotic produces a smaller inhibition zone and becomes less effective. The antibiotic did not teach the surviving bacterium to resist; it selected bacteria already able to survive. Giving the drug for an unrelated viral infection would add selection pressure without treating the virus. Essential-only use reduces unnecessary opportunities for resistant populations such as MRSA to increase and spread.

Common misconceptions and corrections

  • Defining every chemical as a drug. Use the taken-into-body and reaction-modifying definition.
  • Saying every drug is illegal. Medicines can be drugs.
  • Saying every drug is harmful by definition. Effect and appropriate use depend on the substance and context.
  • Calling an antibiotic a pathogen. It is a medicinal drug.
  • Saying antibiotics treat all infections. Their named use is bacterial infection.
  • Saying antibiotics kill viruses. Viruses lack the bacterial targets.
  • Saying severe viral symptoms require antibiotics automatically. Severity does not change pathogen type.
  • Saying a bacterial secondary infection proves the virus was killed. The antibiotic acts on the bacterial infection.
  • Calling every pathogen a bacterium. Pathogens include other disease-causing agents.
  • Saying resistance means bacteria grow more slowly. It means the antibiotic is less effective against them.
  • Saying the patient becomes antibiotic-resistant. Bacteria become resistant.
  • Saying the antibiotic deliberately creates a useful mutation. Selection favours resistant variation.
  • Saying bacteria choose to adapt. Survival and reproduction change population composition.
  • Saying all bacteria die during treatment. Resistant bacteria may survive.
  • Omitting reproduction after survival. Resistant descendants increase the resistant proportion.
  • Saying resistance makes the antibiotic stronger. It reduces effectiveness.
  • Saying resistance to one drug guarantees resistance to all. Resistance can be drug-specific.
  • Saying unnecessary viral treatment has no biological effect. It can select among exposed bacteria.
  • Interpreting essential-only use as never treating bacterial disease. Appropriate treatment remains important.
  • Sharing leftover antibiotics. Drug and dose may not match the infection and add inappropriate exposure.
  • Calling MRSA a virus. It is resistant bacteria.
  • Calling MRSA an antibiotic. It is the organism against which some antibiotics are ineffective.
  • Saying MRSA resistance develops in the human cells. Resistance belongs to bacterial cells.
  • Calling any small inhibition zone proof of resistance. Dose and method conditions must be controlled.
  • Comparing zone sizes from different bacterial strains without qualification. Strain and conditions affect the result.
  • Omitting a no-antibiotic control. It confirms normal bacterial growth under the test conditions.
  • Culturing unknown pathogens for a school comparison. Use approved safe organisms and supervised methods.
  • Importing alcohol, heroin, addiction and tolerance into Topic 15. They are not listed in the current official boundary.

Assessment guidance

Start with the exact drug definition, then restrict antibiotic claims to bacterial infections. When explaining viral non-response, connect lack of bacterial structures and processes to the absence of a suitable antibiotic target. Resistance questions should follow a population chain: variation, antibiotic selection pressure, susceptible death, resistant survival, reproduction and rising resistant proportion. Explain essential-only use as reducing unnecessary selection while preserving appropriate treatment. For MRSA, state that it is resistant bacteria. On inhibition-zone data, compare only controlled conditions and separate an observation from the resistance inference and alternative method explanations.

Retrieval practice

Write a bacteria-versus-virus antibiotic decision tree, then reconstruct the six-stage selection chain from mixed variation to reduced drug effectiveness. Evaluate five prescribing scenarios for essential use, interpret three controlled inhibition-zone datasets and correct statements that place resistance in the patient, virus or antibiotic rather than in bacterial populations.

Theory and practical ownership

This theory note owns the drug definition, bacterial and viral distinction, resistance selection, essential-use reasoning and MRSA interpretation. The separate Biology practical hub owns approved-organism inhibition tests, aseptic technique, controls, safe incubation, zone measurement, tables and evaluation. It excludes culture of unknown or clinical microorganisms.

Return to the Biology theory hub.

Official source

Cambridge International, Biology 0610 syllabus for examinations in 2026, 2027 and 2028 and Biology 0970 syllabus for examinations in 2026, 2027 and 2028, Topic 15 section 15.1 Drugs.

Check this topic from memory

Attempt the matching topic bank before reopening the notes. Use each missed idea to decide what to review next.

Start the topic quiz

Sources

  1. Cambridge IGCSE Biology 0610 syllabus for 2026-2028
  2. Cambridge IGCSE (9-1) Biology 0970 syllabus for 2026-2028